Peijia Medical Limited (FRA:4WO)

Germany flag Germany · Delayed Price · Currency is EUR
0.605
+0.015 (2.54%)
At close: Dec 4, 2025
35.04%
Market Cap 409.04M
Revenue (ttm) 79.36M
Net Income (ttm) -26.77M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 64
Open 0.605
Previous Close 0.590
Day's Range 0.605 - 0.605
52-Week Range 0.418 - 1.010
Beta n/a
RSI 46.90
Earnings Date Nov 21, 2025

About Peijia Medical

Peijia Medical Limited, together with its subsidiaries, engages in the research, development, manufacturing, and sales of transcatheter valve therapeutic and neurointerventional procedural medical devices in the People’s Republic of China. It operates through Transcatheter Valve Therapeutic Business, Neurointerventional Business, and Future Technology Business segments. The company products include transcatheter aortic valve replacement (TAVR) systems, crosslinked dry-tissue and polymeric tri leaflet TAVR systems, transcatheter aortic valve sys... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2012
Employees 1,047
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 4WO
Full Company Profile

Financial Performance

In 2024, Peijia Medical's revenue was 615.48 million, an increase of 39.53% compared to the previous year's 441.13 million. Losses were -226.58 million, -42.28% less than in 2023.

Financial numbers in CNY Financial Statements

News

There is no news available yet.